Literature DB >> 24975883

Kidney injury and mortality after transcatheter aortic valve implantation in a routine clinical cohort.

Renate B Schnabel1, Moritz Seiffert, Sandra Wilde, Johannes Schirmer, Dietmar H Koschyk, Lenard Conradi, Francisco Ojeda, Stephan Baldus, Hermann Reichenspurner, Stefan Blankenberg, Hendrik Treede, Patrick Diemert.   

Abstract

OBJECTIVES: We aimed at identifying predictors of renal impairment and its impact on long-term outcome after transcatheter aortic valve implantation (TAVI).
BACKGROUND: Renal impairment is common in mostly elderly, multimorbid patients undergoing TAVI. The risk of periprocedural renal function impairment and its association with outcome is incompletely understood.
METHODS: In 458 consecutive patients (mean age, 80.6 ± 7.0 years, 52.2% women) who underwent routine TAVI procedures, we assessed estimated glomerular filtration rate (eGFR) at baseline, during 72-hr postprocedure and at discharge. Over a median follow-up of 0.96 years, we observed 142 deaths.
RESULTS: In multivariable-adjusted models, predictors of renal function deterioration within 72 hr were baseline eGFR (β = 0.83, 95% confidence interval [CI] = 0.76/0.91; P < 0.0001), body mass index (β = -1.20, 95% CI = 1.77/-0.62; P < 0.0001), and major access site complications (β = -14.82, 95% CI = -26.52/-3.11; P = 0.013) including bleeding (β = -11.97, 95% CI = -21.05/-2.89; P = 0.0099). Strongest renal function predictor of 1-year mortality in risk factor adjusted analyses was the change of eGFR within 72 hr (odds ratio, 0.97; 95% CI = 0.96/0.98; P < 0.0001). The addition of information on the change of eGFR increased the C-statistic of the logistic EuroSCORE (P = 0.021).
CONCLUSIONS: In our routine TAVI sample, baseline eGFR, body mass index, and major access site complications mainly owing to bleeding were correlates of acute kidney injury after TAVI. Acute renal impairment was a risk factor for mortality and adverse cardiovascular events which provided risk information beyond the EuroSCORE.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  CHF-congestive heart failure; CRI-chronic renal insufficiency; VALV-valvular heart disease

Mesh:

Year:  2014        PMID: 24975883     DOI: 10.1002/ccd.25588

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

Review 1.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

2.  Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and Registry.

Authors:  Nirat Beohar; Darshan Doshi; Vinod Thourani; Hanna Jensen; Susheel Kodali; Feifan Zhang; Yiran Zhang; Charles Davidson; Patrick McCarthy; Michael Mack; Samir Kapadia; Martin Leon; Ajay Kirtane
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

3.  Transcatheter aortic valve implantation in patients with pre-existing chronic kidney disease.

Authors:  Mohammed Shamim Rahman; Rajan Sharma; Stephen J D Brecker
Journal:  Int J Cardiol Heart Vasc       Date:  2015-04-22

4.  SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve.

Authors:  Olaf Wendler; Gerhard Schymik; Hendrik Treede; Helmut Baumgartner; Nicolas Dumonteil; Franz-Josef Neumann; Giuseppe Tarantini; José Luis Zamorano; Alec Vahanian
Journal:  Eur Heart J       Date:  2017-09-21       Impact factor: 29.983

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.